| 标题 |
Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet. Infectious Diseases (Print) 作者:Zhiqiang Song; Liya Zhou; Weihong Wang; Cheng Lan; Tongyu Tang; et al 出版日期:2025-09-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)